MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TOIIW made $502,729K in revenue. -$60,606K in net income. Net profit margin of -12.06%.

Income Overview

Revenue
$502,729K
Net Income
-$60,606K
Net Profit Margin
-12.06%
EPS
-$0.54
Unit: Thousand (K) dollars
Revenue Breakdown
    • Health Care Specialty Pharmacy
    • Health Care Patient Service
    • Clinical Research Trials And Oth...
Revenue Breakdown
    • Health Care Specialty Pharmacy
    • Fee For Service
    • Capitated Revenue
    • Clinical Research Trials And Oth...

Income Statement
2025-12-31
Total operating revenue
502,729
Direct costs-Health Care Patient Service
205,502
Direct costs-Health Care Specialty Pharmacy
220,558
Direct costs-Clinical Research Trials And Other Revenue
234
Selling, general and administrative expense
105,574
Depreciation and amortization
6,944
Total operating expenses
538,812
Loss from operations
-36,083
Interest expense, net
11,276
Change in fair value of derivative warrant liabilities
247
Change in fair value of conversion option derivative liabilities
-12,206
Other, net
-925
Total other non-operating expense
-24,654
Loss before provision for income taxes
-60,737
Income tax benefit
-131
Net loss
-60,606
Basic EPS
-0.54
Diluted EPS
-0.54
Basic Average Shares
92,389,381
Diluted Average Shares
92,389,381
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$60,606K Income tax benefit-$131K Loss beforeprovision for income taxes-$60,737K Health Care SpecialtyPharmacy$269,176K Health Care PatientService$228,991K Clinical Research TrialsAnd Other Revenue$4,562K Loss from operations-$36,083K Total othernon-operating expense-$24,654K Total operatingrevenue$502,729K Total operatingexpenses$538,812K Change in fair value ofconversion option...-$12,206K Interest expense, net$11,276K Other, net-$925K Change in fair value ofderivative warrant...$247K Direct costs-HealthCare Specialty...$220,558K Direct costs-HealthCare Patient Service$205,502K Selling, general andadministrative expense$105,574K Depreciation andamortization$6,944K Direct costs-ClinicalResearch Trials And Other...$234K

Oncology Institute, Inc. (TOIIW)

Oncology Institute, Inc. (TOIIW)